n = 98 | |
---|---|
Male, n (%) | 49 (50.0) |
Age, median (IQR) | 54.5 (46.2–66.7) |
BM+, n (%) | 13 (13.3) |
CNS+, n (%) | 2 (2.0) |
Extranodal sites ≥2, n (%) a | 7 (7.1) |
ECOG > 2, n (%) b | 50 (50.0) |
Bulky disease, n (%) b | 44 (44.9) |
B symptoms, n (%) a | 66 (67.3) |
Stage, n (%) c | |
I | 10 (10.2) |
II | 30 (30.6) |
III | 13 (13.2) |
IV | 41 (41.8) |
IPI, n (%) d | |
Low risk | 24 (24.5) |
Low-intermediate | 20 (20.4) |
Intermediate-high | 22 (22.4) |
High risk | 27 (27.5) |